Targeting human caseinolytic protease P (ClpP) as a novel therapeutic strategy in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting human caseinolytic protease P (ClpP) as a novel therapeutic strategy in ovarian cancer

Published:2022-06 Issue:1 Volume:1 Page:
ISSN:2769-6448
Container-title:MedComm – Oncology
language:en
Short-container-title:MedComm – Oncology

Author:

Luo Baozhu¹,Zhang Jiangnan¹,Qiao Wenliang²,Zhou Yuanzhen¹,Huang Jiasheng¹,Yang Tao³,Luo Youfu¹^ORCID

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, West China Medical School Sichuan University Chengdu China

2. Lung Cancer Center, West China Medical School Sichuan University Chengdu China

3. Laboratory of Human Disease and Immunotherapies, West China Hospital Sichuan University Chengdu China

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mog2.14

Reference32 articles.

1. Kinase Inhibitors and Ovarian Cancer

2. Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

3. Mitochondria in Health and Diseases

4. Mapping Gene Associations in Human Mitochondria using Clinical Disease Phenotypes

5. A human homologue of Escherichia coli ClpP caseinolytic protease: recombinant expression, intracellular processing and subcellular localization

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP